Bioceres Crop Solutions Past Earnings Performance
Past criteria checks 2/6
Bioceres Crop Solutions has been growing earnings at an average annual rate of 47.5%, while the Chemicals industry saw earnings growing at 11% annually. Revenues have been growing at an average rate of 24.2% per year. Bioceres Crop Solutions's return on equity is 1.1%, and it has net margins of 0.6%.
Key information
47.5%
Earnings growth rate
51.2%
EPS growth rate
| Chemicals Industry Growth | 13.1% |
| Revenue growth rate | 24.2% |
| Return on equity | 1.1% |
| Net Margin | 0.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Bioceres Crop Solutions makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 441 | 2 | 103 | 17 |
| 30 Jun 24 | 465 | 3 | 107 | 17 |
| 31 Mar 24 | 446 | 3 | 106 | 16 |
| 31 Dec 23 | 455 | 22 | 104 | 16 |
| 30 Sep 23 | 409 | 14 | 102 | 16 |
| 30 Jun 23 | 419 | 19 | 99 | 15 |
| 31 Mar 23 | 416 | 15 | 95 | 13 |
| 31 Dec 22 | 391 | -19 | 88 | 11 |
| 30 Sep 22 | 389 | -8 | 78 | 9 |
| 30 Jun 22 | 328 | -7 | 65 | 7 |
| 31 Mar 22 | 308 | -2 | 58 | 7 |
| 31 Dec 21 | 275 | 4 | 52 | 6 |
| 30 Sep 21 | 231 | 1 | 46 | 6 |
| 30 Jun 21 | 207 | -7 | 45 | 6 |
| 31 Mar 21 | 174 | -5 | 37 | 4 |
| 31 Dec 20 | 164 | -7 | 35 | 4 |
| 30 Sep 20 | 178 | 3 | 34 | 4 |
| 30 Jun 20 | 172 | 3 | 33 | 4 |
| 31 Mar 20 | 174 | 0 | 36 | 5 |
| 31 Dec 19 | 167 | -18 | 36 | 5 |
| 30 Sep 19 | 167 | -23 | 36 | 4 |
| 30 Jun 19 | 160 | -18 | 34 | 4 |
| 31 Mar 19 | 142 | -26 | 29 | 3 |
| 31 Dec 18 | 145 | -8 | 28 | 3 |
| 30 Sep 18 | 129 | -13 | 29 | 4 |
| 30 Jun 18 | 133 | -11 | 31 | 4 |
| 30 Jun 17 | 94 | -12 | 27 | 4 |
| 31 Dec 16 | 41 | -6 | 8 | 1 |
| 31 Dec 15 | 5 | -1 | 1 | 0 |
Quality Earnings: BIOX has high quality earnings.
Growing Profit Margin: BIOX's current net profit margins (0.6%) are lower than last year (3.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BIOX has become profitable over the past 5 years, growing earnings by 47.5% per year.
Accelerating Growth: BIOX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: BIOX had negative earnings growth (-82.2%) over the past year, making it difficult to compare to the Chemicals industry average (-6.6%).
Return on Equity
High ROE: BIOX's Return on Equity (1.1%) is considered low.